Clinical Trials in Philadelphia

Showing 4681-4700 of 20,904 trials

AR Ruler to Improve Safety and Clinical Workflow During PICC Placement

NCT05399875

The purpose of this study is to assess the utility of an augmented reality virtual ruler during placement of peripherally inserted central catheters.

Insertion of Peripherally Inserted Central Catheter

University of Pennsylvania20 participantsStarted Sep 2022

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease

NCT03729362

This is a phase 3 double-blind randomized study to study the efficacy and safety of intravenous ATB200 Co-administered with oral AT2221 in adult subjects with Late Onset Pompe Disease compared with Alglucosidase Alfa/placebo.

Pompe Disease (Late-onset)

Amicus Therapeutics125 participantsStarted Dec 2018

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Irvine, California, United States +70 more locations

AR Ruler to Improve Safety and Clinical Workflow During PICC Placement

A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease

Find Trials by Condition in Philadelphia

LiveSMART Trial to Prevent Falls in Patients With Cirrhosis

A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants

Abatacept in Immune Checkpoint Inhibitor Myocarditis

Prevention and Treatment of Patient Before, During, and After Covid-19 Infection

Cough Management Wellness App for Refractory or Unexplained Chronic Cough

A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug

Retrospective Study of Suture Tape for Soft Tissue Reconstruction in Patients Suffering From Lateral Ankle Instability

Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

Study of Lademirsen (SAR339375) in Patients With Alport Syndrome

A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04)

A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)

A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis

SPRINT: Signature for Pain Recovery IN Teens

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)